Détail d'une personne de l'annuaire - fr | Cancéropôle Est, la recherche innovante dans la lutte contre le cancer

Association Between Baseline Hemodynamic Indices, Cardiotoxicity Risk and Survival in Women with Breast Cancer.

Decorads CE, Lambert A, Roch V, Imbert L, Perrin M, Claudin M, Doyen M, Citerne Q, Lamiral Z, Peiffert D, Henneton C, Marie PY

J Nucl Cardiol. 2024 03 18;:101849

Brachytherapy for favorable prognostic prostate cancer in men up to 60 years of age: Long term follow-up.

Jacques J, Sahki N, Meknaci É, Eschwege P, Peiffert D, Demogeot N

Brachytherapy. 2024 03 12;:

Prospective results for 5-year survival and toxicity of moderately hypofractionated radiotherapy with simultaneous integrated boost (SIB) in (very) high-risk prostate cancer.

Masson I, Larriviere L, Mahé MA, Azria D, Pommier P, Mesgouez-Nebout N, Giraud P, Peiffert D, Chauvet B, Dudouet P, Salem N, Noël G, Khalifa J, Latorzeff I, Guérin-Charbonnel C, Supiot S

Clin Transl Radiat Oncol. 2024 01;44:100702

Interstitial brachytherapy for lip carcinomas: Comparison between Ir-192 low-dose-rate and high-dose-rate treatment.

Cuenin M, Salleron J, Peiffert D, Meknaci É, Gallet P, Abushama Y, Py JF, Renard S

Cancer Radiother. 2023 12 9;:

CyberKnife stereotactic radiation therapy for stage I lung cancer and pulmonary oligometastases: is fiducial implantation still relevant?-a cohort study.

Oudin V, Salleron J, Marchesi V, Peiffert D, Khadige M, Faivre JC

J Thorac Dis. 2023 09 28;15(9):4636-4647

Can we predict the cardiac benefit of deep inspiration breath hold for left breast and regional nodal irradiation?

Trampetti I, Cuenin M, Gérard K, Salleron J, Peiffert D, Charra-Brunaud C

Cancer Radiother. 2023 08 2;:

A Multicenter Phase 2 Study of Ultrahypofractionated Stereotactic Boost After External Beam Radiotherapy in Intermediate-risk Prostate Carcinoma: A Very Long-term Analysis of the CKNO-PRO Trial.

Pasquier D, Nickers P, Peiffert D, Maingon P, Pommier P, Lacornerie T, Tresch E, Barthoulot M, Lartigau E

Eur Urol Open Sci. 2023 08;54:80-87

Hypofractionated radiotherapy for invasive squamous cell carcinoma of the scalp in the elderly: Efficacy and tolerance, preliminary results.

Jacques J, Renard S, Demogeot N, Faivre JC, Peiffert D

Cancer Radiother. 2023 05 11;:

Treatment, outcome, and prognostic factors in non-metastatic anal cancer: the French nationwide cohort study FFCD-ANABASE.

Vendrely V, Lemanski C, Pommier P, LE Malicot K, Saint A, Rivin Del Campo E, Regnault P, Baba-Hamed N, Ronchin P, Crehange G, Tougeron D, Menager-Tabourel E, Diaz O, Hummelsberger M, Minsat M, Drouet F, Larrouy A, Peiffert D, Lievre A, Zasadny X, Hautefeuille V, Mornex F, Lepage C, Quero L,

Radiother Oncol. 2023 02 20;:109542

The Safety and Efficacy of Salvage Stereotactic Radiation Therapy in Patients with Intraprostatic Tumor Recurrence After Previous External Radiation Therapy: Phase 1 Results from the GETUG-AFU 31 Study.

Pasquier D, Lacornerie T, Supiot S, Pommier P, Quivrin M, Simon JM, Loos G, Meyer E, Calais G, Peiffert D, Vandendorpe B, Aymes E, Leguillette C, Brihoum M, Nenan S, Cormier L, Le Deley MC, Lartigau EF

Eur Urol Oncol. 2023 02 6;:

DOSIMETRIC PREDICTIVE FACTORS FOR FACIAL NERVE PARALYSIS AFTER CYBERKNIFE® STEREOTACTIC RADIOTHERAPY FOR VESTIBULAR SCHWANNOMAS: A SINGLE INSTITUTION EXPERIENCE OF 88 PATIENTS.

Gehin W, Lassalle B, Salleron J, Anxionnat R, Peiffert D, Marchesi V, Bernier-Chastagner V

Radiother Oncol. 2023 02 1;:109519

Prognostic factors of local control and progression-free survival in AJCC stages T1 and T2 cervical cancer patients treated with adjuvant brachytherapy after chemoradiotherapy.

Faivre JC, Jung P, Salleron J, Baumard F, Courrech F, Marchal F, Peiffert D, Renard S, Charra-Brunaud C

J Contemp Brachytherapy. 2023 02;15(1):27-36

Could conventionally fractionated radiation therapy coupled with stereotactic body radiation therapy improve local control in bone oligometastases?

Py JF, Salleron J, Vogin G, Courrech F, Teixeira P, Colnat-Coulbois S, Baumard F, Thureau S, Supiot S, Peiffert D, Oldrini G, Faivre JC

Cancer Radiother. 2023 01 12;:

Outcomes following brachytherapy boost for intermediate- and high-risk prostate cancer: a retrospective bicenter study by the SFRO Brachytherapy Group.

Ka K, Schiappa R, Terlizzi M, Mallet F, Martin E, Chand ME, Demogeot N, Peiffert D, Pommier P, Quivrin M, Kissel M, Pasquier C, Khalifa J, Hannoun-Levi JM, Blanchard P

Radiother Oncol. 2023 01 10;:109460

Acute skin toxicity of conventional fractionated versus hypofractionated radiotherapy in breast cancer patients receiving regional node irradiation: the real-life prospective multicenter HYPOBREAST cohort.

Bruand M, Salleron J, Guihard S, Crety CM, Liem X, Pasquier D, Lamrani-Ghaouti A, Charra-Brunaud C, Peiffert D, Clavier JB, Desandes E, Faivre JC

BMC Cancer. 2022 12 16;22(1):1318

Resident training in brachytherapy in France: A 10-year update after the first survey of SFJRO members.

Kissel M, Ollivier L, Fumagalli I, Pommier P, Chargari C, Blanchard P, Peiffert D, Hannoun-Levi JM,

J Contemp Brachytherapy. 2022 12;14(6):501-511

Impact of external beam pelvic radiotherapy of endometrial carcinoma: A focus on chronic digestive toxicity.

Demogeot N, Salleron J, Beckendorf V, Peiffert D, Levitchi M, Charra-Brunaud C, Renard S

Cancer Radiother. 2022 Feb 13;:

Obituary for Monique Pernot M.D. (1928-2021).

Hannoun-Levi JM, Peiffert D

Brachytherapy. 2022 Jan 31;:

Adapted Fencing for Patients With Invasive Breast Cancer: The RIPOSTE Pilot Randomized Controlled Trial.

Omorou AY, Peiffert D, Rotonda C, Van Hoye A, Allado E, Hily O, Temperelli M, Chenuel B, Hornus-Dragne D, Poussel M

Front Sports Act Living. 2022 ;4:786852

Prostate cancer brachytherapy: SFRO guidelines 2021.

Pommier P, Ferré M, Blanchard P, Martin É, Peiffert D, Robin S, Hannoun-Lévi JM, Marchesi V, Cosset JM

Cancer Radiother. 2021 Dec 22;:

Radiotherapy for penile cancers.

Escande A, Peiffert D, Dejean C, Hannoun-Lévi JM, Cordoba A, Pommier P, Haie-Méder C, Chargari C

Cancer Radiother. 2021 Dec 20;:

Radiotherapy of anal canal cancer.

Peiffert D, Huguet F, Vendrely V, Moureau-Zabotto L, Rivin Del Campo E, Créhange G, Dietmann AS, Moignier A

Cancer Radiother. 2021 Dec 16;:

Role of radiotherapy in the management of vulvar cancer: Recommendations of the French society for radiation oncology.

Chargari C, Petit A, Escande A, Peignaux K, Lafond C, Peiffert D, Hannoun-Lévi JM, Durdux C, Haie-Méder C

Cancer Radiother. 2021 Dec 16;:

Role of radiotherapy in the treatment of primary vaginal cancer: Recommendations of the French society for radiation oncology.

Chargari C, Peignaux K, Escande A, Lafond C, Peiffert D, Petit A, Hannoun-Lévi JM, Durdux C, Haie-Méder C

Cancer Radiother. 2021 Dec 16;:

Hepatic tumours and radiotherapy.

Rio E, Mornex F, Maingon P, Peiffert D, Parent L

Cancer Radiother. 2021 Dec 14;:

Rectal cancer radiotherapy.

Vendrely V, Rivin Del Campo E, Modesto A, Jolnerowski M, Meillan N, Chiavassa S, Serre AA, Gérard JP, Créhanges G, Huguet F, Lemanski C, Peiffert D

Cancer Radiother. 2021 Dec 14;:

Best practice in brachytherapy.

Hannoun-Lévi JM, Chargari C, Blanchard P, Pommier P, Ollivier L, Ferré M, Peiffert D

Cancer Radiother. 2021 Dec 13;:

Exclusive Chemoradiotherapy With or Without Radiation Dose Escalation in Esophageal Cancer: Multicenter Phase 2/3 Randomized Trial CONCORDE (PRODIGE-26).

Crehange G, M'vondo C, Bertaut A, Pereira R, Rio E, Peiffert D, Gnep K, Benezery K, Ronchin P, Noel G, Mineur L, Drouillard A, Blanc J, Rouffiac M, Boustani J

Int J Radiat Oncol Biol Phys. 2021 Nov 1;111(3S):S5

[Dose optimization in 3D pulsed dose rate brachytherapy for patients with locally advanced cervical cancer: A French multicenter phase II trial].

Charra-Brunaud C, Salleron J, Menoux I, Peignaux K, Ducassou A, Petit A, Pommier P, Barillot I, Serre AA, Thomas L, Delannes M, Thibouw D, Antoni D, Renard S, Peiffert D

Cancer Radiother. 2021 Jul 20;:

OLIGOPELVIS GETUG P07, a Multicenter Phase II Trial of Combined High-dose Salvage Radiotherapy and Hormone Therapy in Oligorecurrent Pelvic Node Relapses in Prostate Cancer.

Supiot S, Vaugier L, Pasquier D, Buthaud X, Magné N, Peiffert D, Sargos P, Crehange G, Pommier P, Loos G, Hasbini A, Latorzeff I, Silva M, Denis F, Lagrange JL, Morvan C, Campion L, Blanc-Lapierre A

Eur Urol. 2021 Jul 8;:

Interstitial multi-catheter breast brachytherapy: Technical aspects and experience feedback in a comprehensive cancer center.

Bruand M, Renard S, Salleron J, Meknaci E, Charra-Brunaud C, Peiffert D

Cancer Radiother. 2021 Jun 16;:

Locoregional relapses in the accord12/0405-prodige 02 study: dosimetric study and risk factors.

Meillan N, Orthuon A, Chauchat P, Atlani D, Bouche O, Chaulin B, David C, Deberne M, Debrigode C, Kao W, Keller A, Laharie H, Lamezec B, Lemanski C, Magné N, Mahé MA, Mere P, Moureau-Zabotto L, Peiffert D, Pointreau Y, Quéro L, Racadot S, Roca S, Sargos P, Servagi S, Vendrely V, ElianeTang, Doyen J, Huguet F

Radiother Oncol. 2021 Jun 15;:

A NGS-based Blood Test for the Diagnosis of Invasive HPV-associated Carcinomas with Extensive Viral Genomic Characterization.

Sastre-Garau X, Diop M, Martin F, Dolivet G, Marchal F, Charra-Brunaud C, Peiffert D, Leufflen L, Dembele B, Demange J, Tosti P, Thomas J, Leroux A, Merlin JL, Diop-Ndiaye H, Costa JM, Salleron J, Harle A

Clin Cancer Res. 2021 Jun 9;:

High-dose-rate brachytherapy for facial skin cancer: Outcome and toxicity assessment for 71 cases.

Renard S, Salleron J, Py JF, Cuenin M, Buchheit I, Marchesi V, Huger S, Meknaci E, Peiffert D

Brachytherapy. 2021 Mar 5;:

Long-term outcome of Stereotactic Body Radiation Therapy for patient with unresectable liver metastases from colorectal cancer.

Py JF, Salleron J, Courrech F, Beckendorf V, Croisé-Laurent V, Peiffert D, Vogin G, Dietmann AS

Cancer Radiother. 2021 Feb 19;:

Cost and Toxicity Comparisons of Two IMRT Techniques for Prostate Cancer: A Micro-Costing Study and Weighted Propensity Score Analysis Based on a Prospective Study.

Masson I, Bellanger M, Perrocheau G, Mahé MA, Azria D, Pommier P, Mesgouez-Nebout N, Giraud P, Peiffert D, Chauvet B, Dudouet P, Salem N, Noël G, Khalifa J, Latorzeff I, Guérin-Charbonnel C, Supiot S

Front Oncol. 2021 ;11:781121

[Lung cancer and pulmonary metastasis treated by stereotactic radiosurgery: Evaluation of the relevance of realisation of 3 4D CT by the RPM technique].

Khadige M, Peiffert D, Buchheit I, Salleron J, Peignaux-Casasnovas K, Bidault F, Martin E

Cancer Radiother. 2020 Dec 26;:

[Seeking colleagues' advice when facing complex clinical situations].

Blanchard P, Peiffert D, Truc G

Cancer Radiother. 2020 Aug 19;:

[Can stereotactic body radiotherapy replace brachytherapy for locally advanced cervical cancer? French society for radiation oncology statement].

Chargari C, Renard S, Espenel S, Escande A, Buchheit I, Ducassou A, Peiffert D, Hannoun-Lévi JM

Cancer Radiother. 2020 Aug 1;:

Treatment algorithm and prognostic factors for patients with stage I-III carcinoma of the anal canal: a 20-year multicenter study.

Bruyere D, Monnien F, Colpart P, Roncarati P, Vuitton L, Hendrick E, Lepinoy A, Luquain A, Pilard C, Lerho T, Molimard C, Maingon P, Arnould L, Bone-Lepinoy MC, Dusserre L, Martin L, Reynders C, Ancion M, Peiffert D, Leroux A, Hubert P, Delhorme JB, Ghnassia JP, Woronoff AS, Delvenne P, Prétet JL, Bosset JF, Peulen O, Mougin C, Valmary-Degano S, Herfs M

Mod. Pathol.. 2020 Jul 29;:

[Brachytherapy in France in 2020: State of the art and perspectives from the Groupe curiethérapie de la SFRO].

Hannoun-Lévi JM, Chand MÈ, Blanchard P, Chargari C, Escande A, Pierrat N, Pommier P, Peiffert D

Cancer Radiother. 2020 Jun 20;:

Curative Irradiation Treatment of Hepatocellular Carcinoma: A Multicenter Phase 2 Trial.

Durand-Labrunie J, Baumann AS, Ayav A, Laurent V, Boleslawski E, Cattan S, Bogart E, Le Deley MC, Steen V, Lacornerie T, Peiffert D, Mirabel X

Int. J. Radiat. Oncol. Biol. Phys.. 2020 Jan 27;:

Short-term androgen deprivation therapy combined with radiotherapy as salvage treatment after radical prostatectomy for prostate cancer (GETUG-AFU 16): a 112-month follow-up of a phase 3, randomised trial.

Carrie C, Magné N, Burban-Provost P, Sargos P, Latorzeff I, Lagrange JL, Supiot S, Belkacemi Y, Peiffert D, Allouache N, Dubray BM, Servagi-Vernat S, Suchaud JP, Crehange G, Guerif S, Brihoum M, Barbier N, Graff-Cailleaud P, Ruffion A, Dussart S, Ferlay C, Chabaud S

Lancet Oncol.. 2019 Oct 16;:

Sweet syndrome and erythema nodosum in a case of anal canal cancer during concomitant radiochemotherapy.

Moreau E, Peiffert D, Schmutz JL, Granel-Brocard F, Bursztejn AC

Eur J Dermatol. 2019 Oct 16;:

A multicentre phase II study of hypofractionated stereostatic boost in intermediate risk prostate carcinoma: a 5-year analysis of the CKNO-PRO trial.

Pasquier D, Peiffert D, Nickers P, Maingon P, Pommier P, Lacornerie T, Martinage G, Tresch E, Lartigau E

Int. J. Radiat. Oncol. Biol. Phys.. 2019 Oct 8;:

Pooled Analysis of external-beam RADiotherapy parameters in phase II and phase III trials in radiochemotherapy in Anal Cancer (PARADAC).

Rivin Del Campo E, Matzinger O, Haustermans K, Peiffert D, Glynne-Jones R, Winter KA, Konski AA, Ajani JA, Bosset JF, Hannoun-Levi JM, Puyraveau M, Chakravarthy AB, Meadows H, Northover J, Collette L, Christiaens M, Maingon P

Eur. J. Cancer. 2019 Sep 28;121:130-143

Peiffert D

Cancer Radiother. 2019 Aug 27;:

Psychological and social determinants of physical activity from diagnosis to remission among French cancer patients (PERTINENCE): protocol for a mixed-method study.

Van Hoye A, Omorou Y, Rotonda C, Gendarme S, Tarquinio C, Houtmann B, Peiffert D, Longo R, Martin-Krumm C

BMC Public Health. 2019 Aug 6;19(1):1053

Brachytherapy boost for prostate cancer: A national survey from Groupe curiethérapie - Société française de radiothérapie oncologique.

Lam Cham Kee D, Peiffert D, Hannoun-Lévi JM

Cancer Radiother. 2019 Jul 30;:

Quality Assurance of Dose Escalated Radiation Therapy in a Randomized Trial for Locally Advanced Oesophageal Cancer.

Boustani J, Del Campo ER, Blanc J, Peiffert D, Benezery K, Pereira R, Rio E, Le Prisé E, Créhange G, Huguet F

Int. J. Radiat. Oncol. Biol. Phys.. 2019 Jul 9;:

Hafnium oxide nanoparticles activated by SBRT: a new interventional radiation therapy approach for the treatment of unresectable liver cancers.

De Baere T, Pracht M, Rolland Y, Nguyen F, Bronowicki J, Vendrely V, Cunha AS, Baumann A, Croisé-Laurent V, Rio E, Sourd SL, Gustin P, Perret C, Peiffert D, Deutsch E, Chajon E

Ann. Oncol.. 2019 Jul;30 Suppl 4:iv123-iv124

HPV insertional pattern as a personalized tumor marker for the optimized tumor diagnosis and follow-up of patients with HPV-associated carcinomas: a case report.

Harlé A, Guillet J, Thomas J, Demange J, Dolivet G, Peiffert D, Leroux A, Sastre-Garau X

BMC Cancer. 2019 Mar 28;19(1):277

Intensity-modulated radiation therapy of anal squamous cell carcinoma: Relationship between delineation quality and regional recurrence.

Rouard N, Peiffert D, Rio E, Mahé MA, Delpon G, Marchesi V, Falk AT, Salleron J, Serre AA

Radiother Oncol. 2019 Feb;131:93-100

Hepatocellular carcinoma and liver metastasis treated by hafnium oxide nanoparticles activated by stereotactic body radiation therapy.

Pracht M, Chajon E, de Baere T, Nguyen F, Bronowicki JP, Vendrely V, Baumann AS, Croisé-Laurent V, Rio E, Rolland Y, Le Sourd S, Gustin P, Perret C, Mornex F, Peiffert D, Merle P, Deutsch E

Ann. Oncol.. 2018 Oct;29 Suppl 8:viii240

[Anal canal cancer: In the era of intensity-modulated radiotherapy, outstanding issues].

Peiffert D, Baumann AS, Serre AA, Vendrely V, Rouard N, Faivre JC, Vogin G

Cancer Radiother. 2018 Sep 1;:

Prognostic factors of colostomy free survival in patients presenting with locally advanced anal canal carcinoma: A pooled analysis of two prospective trials (KANAL 2 and ACCORD 03).

Faivre JC, Peiffert D, Vendrely V, Lemanski C, Hannoun-Levi JM, Mirabel X, Stanbury T, Salleron J, Guillemin F

Radiother Oncol. 2018 Aug 29;:

Prostate-specific antigen bounce in patients treated before 60 years old by iodine 125 brachytherapy for prostate cancer is frequent and not a prognostic factor.

Charret J, Baumann AS, Eschwege P, Moreau JL, Bernier V, Falk AT, Salleron J, Peiffert D

Brachytherapy. 2018 Aug 29;:

Absence of correlation between radiation-induced CD8 T-lymphocyte apoptosis and sequelae in patients with prostate cancer accidentally overexposed to radiation.

Vogin G, Merlin JL, Rousseau A, Peiffert D, Harlé A, Husson M, Hajj LE, Levitchi M, Simon T, Simon JM

Oncotarget. 2018 Aug 24;9(66):32680-32689

Cyberknife stereotactic radiation therapy for stage I lung cancer and pulmonary metastases: evaluation of local control at 24 months.

Khadige M, Salleron J, Marchesi V, Oldrini G, Peiffert D, Beckendorf V

J Thorac Dis. 2018 Aug;10(8):4976-4984

NHL-ChirEx: An interprofessional cross-border education initiative in the Greater Region with a focus on radiation morbidity and patient safety.

Vogin G, Fleckenstein J, Servotte JC, Nickers P, Ebersberger A, Mohammad F, Bragard I, Coucke P, Untereiner M, Peiffert D, Braun M,

Radiother Oncol. 2018 Jul 10;:

Validation of a high performance functional assay for individual radiosensitivity in pediatric oncology: a prospective cohort study (ARPEGE).

Bernier-Chastagner V, Hettal L, Gillon V, Fernandes L, Huin-Schohn C, Vazel M, Tosti P, Salleron J, François A, Cérimèle E, Perreira S, Peiffert D, Chastagner P, Vogin G

BMC Cancer. 2018 Jul 6;18(1):719

A phase I/II trial of hafnium oxide nanoparticles activated by radiotherapy in hepatocellular carcinoma and liver metastasis.

Chajon E, Pracht M, De Baere T, Nguyen F, Bronowicki J, Vendrely V, Baumann A, Croisé-Laurent V, Rio E, Rolland Y, Le Sourd S, Gustin P, Perret C, Mornex F, Peiffert D, Merle P, Deutsch E

Ann. Oncol.. 2018 Jun;29 Suppl 5:v92

[Brachytherapy for head and neck cancers].

Peiffert D, Coche-Dequéant B, Lapeyre M, Renard S

Cancer Radiother. 2018 May 29;:

Impact of rectal distension on prostate CBCT-based positioning assessed with 6 degrees-of-freedom couch.

Charret J, Salleron J, Quivrin M, Mazoyer F, Lesueur P, Martin E, Peiffert D, Créhange G

Pract Radiat Oncol. 2018 Mar 9;:

Tumor lymphocyte immune response to preoperative radiotherapy in locally advanced rectal cancer: The LYMPHOREC study.

Mirjolet C, Charon-Barra C, Ladoire S, Arbez-Gindre F, Bertaut A, Ghiringhelli F, Leroux A, Peiffert D, Borg C, Bosset JF, Créhange G

Oncoimmunology. 2018 ;7(3):e1396402

The prognostic value of inflammation-based scores in advanced hepatocellular carcinoma patients prior to treatment with sorafenib.

Conroy G, Salleron J, Belle A, Bensenane M, Nani A, Ayav A, Peiffert D, Lopez A, Baumann C, Barraud H, Bronowicki JP

Oncotarget. 2017 Nov 10;8(56):95853-95864

Modern robot-assisted radiosurgery of cerebral angiomas-own experiences, system comparisons, and comprehensive literature overview.

Feutren T, Huertas A, Salleron J, Anxionnat R, Bracard S, Klein O, Peiffert D, Bernier-Chastagner V

Neurosurg Rev. 2017 Nov 5;:

A retrospective cohort study to assess adjuvant concurrent chemoradiation (CCRT) compared to adjuvant radiation therapy (RT) in the treatment of grade 2 and 3 extremity soft tissue sarcomas.

Nesseler JP, Salleron J, Rios M, Nickers P, Marchal F, Brocard F, Peiffert D, Vogin G

Radiother Oncol. 2017 Sep;:

Docetaxel, Cisplatin, and 5-fluorouracil (DCF) chemotherapy in the treatment of metastatic or unresectable locally recurrent anal squamous cell carcinoma: a phase II study of French interdisciplinary GERCOR and FFCD groups (Epitopes-HPV02 study).

Kim S, Jary M, André T, Vendrely V, Buecher B, François E, Bidard FC, Dumont S, Samalin E, Peiffert D, Pernot S, Baba-Hamed N, El Hajbi F, Bouché O, Desrame J, Parzy A, Zoubir M, Louvet C, Bachet JB, Nguyen T, Abdelghani MB, Smith D, De La Fouchardière C, Aparicio T, Bennouna J, Gornet JM, Jacquin M, Bonnetain F, Borg C

BMC Cancer. 2017 Aug;17(1):574

Effect of bladder distension on doses to organs at risk in Pulsed-Dose-Rate 3D image-guided adaptive brachytherapy for locally advanced cervical cancer.

Nesseler JP, Charra-Brunaud C, Salleron J, Py JF, Huertas A, Meknaci E, Courrech F, Peiffert D, Renard-Oldrini S

Brachytherapy. 2017 Jul;:

[Hypofractionated stereotactic radiotherapy for brain metastasis: Benefit of additional whole brain radiotherapy?]

Royer P, Salleron J, Vogin G, Taillandier L, Clément-Duchêne C, Klein O, Faivre JC, Peiffert D, Bernier V

Cancer Radiother. 2017 Jul;:

Intensity-modulated radiation therapy from 70Gy to 80Gy in prostate cancer: six- year outcomes and predictors of late toxicity.

Jolnerovski M, Salleron J, Beckendorf V, Peiffert D, Baumann AS, Bernier V, Huger S, Marchesi V, Chira C

Radiat Oncol. 2017 Jun;12(1):99

[Evaluation of the French practices in brachytherapy using surveys].

Delattre B, Cormier L, Borgogno C, Descotes JL, Peiffert D, Hannoun-Levi JM, Moreau JL

Prog. Urol.. 2017 Jun;:

Anal cancer: French Intergroup Clinical Practice Guidelines for diagnosis, treatment and follow-up.

Moureau-Zabotto L, Vendrely V, Abramowitz L, Borg C, Francois E, Goere D, Huguet F, Peiffert D, Siproudhis L, Ducreux M, Bouché O

Dig Liver Dis. 2017 May;:

[Cancer, radiotherapy and immune system].

Nesseler JP, Peiffert D, Vogin G, Nickers P

Cancer Radiother. 2017 May;:

[Comparison of survival and chronic gastrointestinal toxicities in patients with locally advanced cervical cancer, treated by conventional or intensity-modulated radiation technique].

Gamelon-Bénichou C, Oldrini S, Charra-Brunaud C, Vogin G, Salleron J, Peiffert D

Cancer Radiother. 2017 Apr;:

FIGO stage IB1 cervical carcinoma: Place and principles of brachytherapy.

Huertas A, Oldrini S, Nesseler JP, Courrech F, Rétif P, Charra-Brunaud C, Peiffert D

Cancer Radiother. 2017 Feb;:

Hypofractionated stereotactic boost in intermediate risk prostate carcinoma: Preliminary results of a multicenter phase II trial (CKNO-PRO).

Pasquier D, Nickers P, Peiffert D, Maingon P, Pommier P, Lacornerie T, Martinage G, Tresch E, Lartigau E

PLoS ONE. 2017 ;12(11):e0187794

Vestibular schwannomas treated with Cyberknife®: clinical outcomes.

Jumeau R, Bondiau PY, Parietti-Winkler C, Salleron J, Civit T, Peiffert D, Bernier-Chastagner V

Tumori. 2016 Dec;102(6):569-573

[Hepatic tumors and radiotherapy].

Rio E, Mornex F, Peiffert D, Huertas A

Cancer Radiother. 2016 Sep;20 Suppl:S174-8

[Prostate cancer brachytherapy].

Pommier P, Guérif S, Peiffert D, Créhange G, Hannoun-Lévi JM, de Crevoisier R

Cancer Radiother. 2016 Sep;20 Suppl:S210-5

[Radiotherapy for anal canal cancers].

Peiffert D, Créhange G, Vendrely V, Baumann AS, Faivre JC, Huger S

Cancer Radiother. 2016 Sep;20 Suppl:S183-8

[Radiotherapy for oral cavity cancers].

Lapeyre M, Biau J, Racadot S, Moreira JF, Berger L, Peiffert D

Cancer Radiother. 2016 Sep;20 Suppl:S116-25

[Radiotherapy of rectal carcinoma].

Peiffert D, Créhange G, Vendrely V, Baumann AS, Faivre JC, Huger S, Serre AA

Cancer Radiother. 2016 Sep;20 Suppl:S179-82

High dose rate brachytherapy with customized applicators for malignant facial skin lesions.

Jumeau R, Renard-Oldrini S, Courrech F, Buchheit I, Oldrini G, Vogin G, Peiffert D

Cancer Radiother. 2016 Jul;20(5):341-6

Influence of Nucleoshuttling of the ATM Protein in the Healthy Tissues Response to Radiation Therapy: Toward a Molecular Classification of Human Radiosensitivity.

, Granzotto A, Benadjaoud MA, Vogin G, Devic C, Ferlazzo ML, Bodgi L, Pereira S, Sonzogni L, Forcheron F, Viau M, Etaix A, Malek K, Mengue-Bindjeme L, Escoffier C, Rouvet I, Zabot MT, Joubert A, Vincent A, Dalla Venezia N, Bourguignon M, Canat EP, d'Hombres A, Thébaud E, Orbach D, Stoppa-Lyonnet D, Radji A, Doré E, Pointreau Y, Bourgier C, Leblond P, Defachelles AS, Lervat C, Guey S, Feuvret L, Gilsoul F, Berger C, Moncharmont C, de Laroche G, Moreau-Claeys MV, Chavaudra N, Combemale P, Biston MC, Malet C, Martel-Lafay I, Laude C, Hau-Desbat NH, Ziouéche A, Tanguy R, Sunyach MP, Racadot S, Pommier P, Claude L, Baleydier F, Fleury B, de Crevoisier R, Simon JM, Verrelle P, Peiffert D, Belkacemi Y, Bourhis J, Lartigau E, Carrie C, De Vathaire F, Eschwege F, Puisieux A, Lagrange JL, Balosso J, Foray N

Int. J. Radiat. Oncol. Biol. Phys.. 2016 Mar;94(3):450-60

[Dosimetric comparaison between VMAT and tomotherapy with para-aortic irradiation for cervix carcinoma].

Renard-Oldrini S, Guinement L, Salleron J, Brunaud C, Huger S, Grandgirard N, Villani N, Marchesi V, Oldrini G, Peiffert D

Cancer Radiother. 2015 Nov 4. pii: S1278-3218(15)00373-X

[Follow-up after radiotherapy of anal canal carcinoma].

Meillan N, Huguet F, Peiffert D

Cancer Radiother. 2015 Oct;19(6-7):610-5

[Head and neck adaptive radiotherapy: A tool for the detection of patients requiring adaptive radiotherapy].

Huger S, Graff P, Marchesi V, Vogin G, Guinement L, Serre AA, Peiffert D

Cancer Radiother. 2015 Sep 3. pii: S1278-3218(15)00170-5

[Recommendations for the management of cancers of the anal canal].

Peiffert D

Cancer Radiother. 2015 Sep 1. pii: S1278-3218(15)00157-2

Stereotactic body radiation therapy as an ablative treatment for inoperable hepatocellular carcinoma.

Huertas A, Baumann AS, Saunier-Kubs F, Salleron J, Oldrini G, Croise-Laurent V, Barraud H, Ayav A, Bronowicki JP, Peiffert D

Radiother Oncol. 2015 May;115(2):211-6

A case-control study of patients with squamous cell carcinoma of the oral cavity and oropharynx treated with pulsed-dose-rate brachytherapy.

Haddad A, Peiffert D, Lapeyre M, Harter V, Buchheit I, Graff P

Brachytherapy. 2014 Nov-Dec;13(6):597-602

Anal cancer: ESMO-ESSO-ESTRO clinical practice guidelines for diagnosis, treatment and follow-up.

Glynne-Jones R, Nilsson PJ, Aschele C, Goh V, Peiffert D, Cervantes A, Arnold D

Eur J Surg Oncol. 2014 Oct;40(10):1165-76

Dose rate in brachytherapy using after-loading machine: pulsed or high-dose rate?

Hannoun-Levi JM, Peiffert D

Cancer Radiother. 2014 Oct;18(5-6):437-40

Radiation plus docetaxel and cisplatin in locally advanced pancreatic carcinoma: a non-comparative randomized phase II trial.

Ducreux M, Giovannini M, Baey C, Llacer C, Bennouna J, Adenis A, Peiffert D, Mornex F, Abbas M, Boige V, Pignon JP, Conroy T, Cellier P, Juzyna B, Viret F

Dig Liver Dis. 2014 Oct;46(10):950-5

Salvage reirradiation for locoregional failure after radiation therapy for prostate cancer: who, when, where and how?

Crehange G, Roach M 3rd, Martin E, Cormier L, Peiffert D, Cochet A, Chapet O, Supiot S, Cosset JM, Bolla M, Chung HT

Cancer Radiother. 2014 Oct;18(5-6):524-34

Anal cancer: ESMO-ESSO-ESTRO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

Glynne-Jones R, Nilsson PJ, Aschele C, Goh V, Peiffert D, Cervantes A, Arnold D

Ann Oncol. 2014 Sep;25 Suppl 3:iii10-20

Impact of dosimetric parameters on local control for patients treated with three-dimensional pulsed dose-rate brachytherapy for cervical cancer.

Boyrie S, Charra-Brunaud C, Harter V, Ducassou A, Kirova Y, Barillot I, Krzisch C, Lang P, Baron MH, Montbarbon X, Delannes M, Peiffert D

Brachytherapy. 2014 Jul-Aug;13(4):326-31

Anal cancer: ESMO-ESSO-ESTRO clinical practice guidelines for diagnosis, treatment and follow-up.

Glynne-Jones R, Nilsson PJ, Aschele C, Goh V, Peiffert D, Cervantes A, Arnold D

Radiother Oncol. 2014 Jun;111(3):330-9

[Evaluation of transit in vivo dosimetry using portal imaging and comparison with measurements using diodes].

Royer P, Marchesi V, Rousseau V, Buchheit I, Wolf D, Peiffert D, Noel A

Cancer Radiother. 2014 Jun;18(3):183-90

[Safety and efficacy of whole breast irradiation with a concomitant boost: analysis of 121 cases treated at the Institute of Cancerology of Lorraine].

Renoult F, Marchal C, Brunaud C, Harter V, Peiffert D

Cancer Radiother. 2014 Jun;18(3):165-70

Evaluation of the Block Matching deformable registration algorithm in the field of head-and-neck adaptive radiotherapy.

Huger S, Graff P, Harter V, Marchesi V, Royer P, Diaz JC, Aouadi S, Wolf D, Peiffert D, Noel A

Phys Med. 2014 May;30(3):301-8

[Contribution of an emergency dermatology consultation in a French cancer centre].

Reigneau M, Granel-Brocard F, Geoffrois L, Poreaux C, Peiffert D, Cuny JF, Bursztejn AC, Waton J, Schmutz JL, Barbaud A

Ann Dermatol Venereol. 2014 May;141(5):375-8

Treatment of hepatic metastases of colorectal cancer by robotic stereotactic radiation (Cyberknife (R)).

Peiffert D, Baumann AS, Marchesi V

J Visc Surg. 2014 Apr;151 Suppl 1:S45-9

Implantation of fiducial markers in the liver for stereotactic body radiation therapy: Feasibility and results.

Oldrini G, Taste-George H, Renard-Oldrini S, Baumann AS, Marchesi V, Troufleau P, Peiffert D, Didot-Moisei A, Boyer B, Grignon B, Henrot P

Diagn Interv Imaging. 2014 Mar 6. pii: S2211-5684(14)00011-4

[Impact of dynamic IMRT and tomotherapy in pelvic cancers: a prospective dosimetric study with 51 patients].

Servagi-Vernat S, Giraud P, Fenoglietto P, Azria D, Lisbona A, de La Rochefordiere A, Zefkili S, Fau P, Resbeut M, Huger S, Peiffert D, Meyer P, Noel G, Mazurier J, Latorzeff I, Biston MC, Pommier P, Ledu D, Garcia R, Chauvet B, Dudouet P, Belhomme S, Kantor G, Mahe MA

Cancer Radiother. 2014 Mar;18(2):111-8

[Brachytherapy training: a survey of French radiation oncology residents].

Fumagalli I, Faivre JC, Thureau S, Bibault JE, Diaz O, Leroy T, Pichon B, Riou O, Fournier C, Hannoun-Levi JM, Peiffert D

Cancer Radiother. 2014 Jan;18(1):28-34

Multi institutional phase II study of concomitant stereotactic reirradiation and cetuximab for recurrent head and neck cancer.

Lartigau EF, Tresch E, Thariat J, Graff P, Coche-Dequeant B, Benezery K, Schiappacasse L, Degardin M, Bondiau PY, Peiffert D, Lefebvre JL, Lacornerie T, Kramar A

Radiother Oncol. 2013 Nov;109(2):281-5

[How to prepare the brachytherapy of the future].

Hannoun-Levi JM, Peiffert D

Cancer Radiother. 2013 Oct;17(5-6):395-9

[Organization and prerequisites for the delegation of dosimetry tasks].

Marchesi V, Peiffert D, Le Tallec P, Aigle D

Cancer Radiother. 2013 Oct;17(5-6):378-82

[Preoperative radiotherapy for rectal cancer: target volumes].

Huertas A, Marchal F, Peiffert D, Crehange G

Cancer Radiother. 2013 Oct;17(5-6):477-85

Radiotherapy for pain: modality of action and indications.

Faivre JC, Janvier L, Berger A, Mathias E, Olivier P, Bensadoun RJ, Peiffert D

Douleur Analg. 2013 Sep;26(3):152-7.

[Development of external quality control protocol for CyberKnife beams dosimetry: preliminary tests multicentre].

Guinement L, Marchesi V, Veres A, Lacornerie T, Buchheit I, Peiffert D

Cancer Radiother. 2013 Jul-Aug;17(4):288-96

[Brachytherapy for anal cancers].

Pommier P, Mirabel X, Hannoun-Levi JM, Malet C, Gerard JP, Peiffert D

Cancer Radiother. 2013 Apr;17(2):143-50

[Brachytherapy for head and neck cancers].

Lapeyre M, Coche-Dequeant B, Moreira JF, Le Bourhis J, Peiffert D

Cancer Radiother. 2013 Apr;17(2):130-5

[Brachytherapy in France: past, present and what future?].

Hannoun-Levi JM, Peiffert D

Cancer Radiother. 2013 Apr;17(2):73-5

[Brachytherapy training].

Hannoun-Levi JM, Marchesi V, Peiffert D

Cancer Radiother. 2013 Apr;17(2):170-3

[Development and perspectives of brachytherapy in France].

Peiffert D, Hannoun-Levi JM

Cancer Radiother. 2013 Apr;17(2):76-80

[Permanent implant prostate cancer brachytherapy: 2013 state-of-the art].

Cosset JM, Hannoun-Levi JM, Peiffert D, Delannes M, Pommier P, Pierrat N, Nickers P, Thomas L, Chauveinc L

Cancer Radiother. 2013 Apr;17(2):111-7

[Safety in brachytherapy].

Marcie S, Marinello G, Peiffert D, Lartigau E

Cancer Radiother. 2013 Apr;17(2):166-9

[Case report of EPPER Syndrome (eosinophilic polymorphic pruritic eruption associated with radiotherapy) in a patient treated against endometrial cancer].

Lam Cham Kee HX, Charra-Brunaud C, Cuny JF, Reigneau M, Vogin G, Peiffert D

Cancer Radiother. 2013 Feb;17(1):54-7

[Intensity modulated radiotherapy for head and neck cancers: ethics and patients selection].

Renard-Oldrini S, Zielinski A, Mecellem H, Graff P, Marchesi V, Peiffert D

Cancer Radiother. 2013 Feb;17(1):1-9

[Functional modeling for risk analysis in radiotherapy].

Reitz A, Petin JF, Levrat E, Noel A, Aigle D, Peiffert D, Graff P

Cancer Radiother. 2012 Dec;16(8):653-60

[Systematic approach for dysfunctional analysis in radiotherapy].

Reitz A, Levrat E, Petin JF, Noel A, Aigle D, Peiffert D, Graff P

Cancer Radiother. 2012 Dec;16(8):667-73

[Metabolic impact of androgen deprivation therapy for prostate cancer].

Andres E, Eschwege P, Lang H, Moreau JL, Peiffert D, Thiery-Vuillemin A, Kleinclauss F

Prog Urol. 2012 Sep;22 Suppl 2:S39-47

[Role of French teams in the development of clinical and translational research in radiation oncology].

Azria D, Ardiet JM, Chauvet B, Denis F, Eschwege F, Hennequin C, Lartigau E, Rocher F, Mahe MA, Maingon P, Mazeron JJ, Metayer Y, Peiffert D, Thureau S, Mornex F

Cancer Radiother. 2012 Sep;16(5-6):386-91

Focal HIFU for prostate cancer.

Crehange G, Azria D, Lartigau E, Peiffert D, Maingon P

Lancet Oncol. 2012 Jul;13(7):e282-3; author reply e284

Impact of 3D image-based PDR brachytherapy on outcome of patients treated for cervix carcinoma in France: results of the French STIC prospective study.

Charra-Brunaud C, Harter V, Delannes M, Haie-Meder C, Quetin P, Kerr C, Castelain B, Thomas L, Peiffert D

Radiother Oncol. 2012 Jun;103(3):305-13

Impact of dosimetric and clinical parameters on clinical side effects in cervix cancer patients treated with 3D pulse-dose-rate intracavitary brachytherapy.

Levitchi M, Charra-Brunaud C, Quetin P, Haie-Meder C, Kerr C, Castelain B, Delannes M, Thomas L, Desandes E, Peiffert D

Radiother Oncol. 2012 Jun;103(3):314-21

Induction chemotherapy and dose intensification of the radiation boost in locally advanced anal canal carcinoma: final analysis of the randomized UNICANCER ACCORD 03 trial.

Peiffert D, Tournier-Rangeard L, Gérard JP, Lemanski C, François E, Giovannini M, Cvitkovic F, Mirabel X, Bouché O, Luporsi E, Conroy T, Montoto-Grillot C, Mornex F, Lusinchi A, Hannoun-Lévi JM, Seitz JF, Adenis A, Hennequin C, Denis B, Ducreux M

J. Clin. Oncol.. 2012 Jun;30(16):1941-8

[Ballistic quality assurance].

Cassol E, Bonnet J, Porcheron D, Mazeron JJ, Peiffert D, Alapetite C

Cancer Radiother. 2012 Jun;16 Suppl:S30-7

[Dosimetric comparison between the intensity modulated radiotherapy with fixed field and Rapid Arc of cervix cancer].

Renard-Oldrini S, Brunaud C, Huger S, Marchesi V, Tournier-Rangeard L, Bouzid D, Harter V, Peiffert D

Cancer Radiother. 2012 May;16(3):209-14

[In response to the presentation of Dr. B. Smith performed during the 2011 San Antonio Breast Cancer Symposium (SABCS) about the results of brachytherapy use for accelerated and partial breast irradiation].

Hannoun-Levi JM, Peiffert D

Cancer Radiother. 2012 May;16(3):244-5

[Surgery and postoperative radiation therapy in primary retroperitoneal sarcomas: experience of the cancer centre Alexis-Vautrin].

Fuks D, Verhaeghe JL, Marchal F, Guillemin F, Beckendorf V, Peiffert D, Leroux A, Rios M, Troufleau P, Marchal C

Cancer Radiother. 2012 May;16(3):194-200

[Intensity-modulated radiation therapy for anal carcinoma].

Peiffert D, Moreau-Claeys MV, Tournier-Rangeard L, Huger S, Marchesi V

Cancer Radiother. 2011 Oct;15(6-7):549-54

[High dose rate vaginal brachytherapy in endometrial cancer after surgery].

Moreau-Claeys MV, Brunaud C, Hoffstetter S, Buchheit I, Peiffert D

Cancer Radiother. 2011 Jun;15(3):169-75

Intradermal tacrolimus prevent scar hypertrophy in a rabbit ear model: a clinical, histological and spectroscopical analysis.

Gisquet H, Liu H, Blondel WC, Leroux A, Latarche C, Merlin JL, Chassagne JF, Peiffert D, Guillemin F

Skin Res Technol. 2011 May;17(2):160-6

Management of patients with head and neck tumours presenting at diagnosis with a synchronous second cancer at another anatomic site.

Graff P, Schipman B, Desandes E, Mecellem H, Toussaint B, Cortese S, Marchal F, Kaminsky MC, Geoffrois L, Peiffert D

Clin Oncol (R Coll Radiol). 2011 Apr;23(3):174-81

High-dose-rate brachytherapy for non-small-cell lung carcinoma: a retrospective study of 226 patients.

Aumont-le Guilcher M, Prevost B, Sunyach MP, Peiffert D, Maingon P, Thomas L, Williaume D, Begue M, Lerouge D, Campion L, Mahe MA

Int J Radiat Oncol Biol Phys. 2011 Mar 15;79(4):1112-6

MeMoPratic' VDHA guide: optimizing medical management from affected upper gastrointestinal system.

Faivre JC, Mecellem H, Albertini L, Belle A, Henry A, Rousselot H, Cretineau N, Montaut T, Chone L, Cabessut S, Bevilacqua S, Henneton C, Scotte F, Launay-Vacher V, Chenot ED, Desandes E, Toussaint S, Peiffert D, Krakowski I

. 2011 Mar;13(2-3):116-21.

MeMoPratic' VDHA guide: pain and supportive care: optimizing medical management from affected upper gastrointestinal system.

Faivre JC, Mecellem H, Albertini L, Belle A, Henry A, Rousselot H, Cretineau N, Montaut T, Chone L, Cabessut S, Bevilacqua S, Henneton C, Scotte F, Launay-Vacher V, Chenot ED, Desandes E, Toussaint S, Peiffert D, Krakowski I

. 2011 Mar;24(1):56-60.

Docetaxel- and 5-FU-concurrent radiotherapy in patients presenting unresectable locally advanced pancreatic cancer: a FNCLCC-ACCORD/0201 randomized phase II trial's pre-planned analysis and case report of a 5.5-year disease-free survival.

Oberic L, Viret F, Baey C, Ychou M, Bennouna J, Adenis A, Peiffert D, Mornex F, Pignon JP, Celier P, Berille J, Ducreux M

Radiat Oncol. 2011 Sep 26;6:124.

Phase II randomised trial of chemoradiotherapy with FOLFOX4 or cisplatin plus fluorouracil in oesophageal cancer.

Conroy T, Yataghene Y, Etienne PL, Michel P, Senellart H, Raoul JL, Mineur L, Rives M, Mirabel X, Lamezec B, Rio E, Le Prise E, Peiffert D, Adenis A

Br J Cancer. 2010 Oct 26;103(9):1349-55

[Normal tissue tolerance to external beam radiation therapy: anal canal]

Moreau-Claeys MV, Peiffert D

Cancer Radiother. 2010 Jul;14(4-5):359-62

[Economic assessment of pulsed dose-rate (PDR) brachytherapy with optimized dose distribution for cervix carcinoma]

Remonnay R, Morelle M, Pommier P, Haie-Meder C, Quetin P, Kerr C, Delannes M, Castelain B, Peignaux K, Kirova Y, Romestaing P, Williaume D, Krzisch C, Thomas L, Lang P, Baron MH, Cussac A, Lesaunier F, Maillard S, Barillot I, Charra-Brunaud C, Carrere MO, Peiffert D

Cancer Radiother. 2010 Jun;14(3):161-8

[National breast cancer brachytherapy survey in France: Results and perspectives in 2009]

Hannoun-Levi JM, Hennequin C, Pommier P, Izar F, Thomas L, Le Scodan R, Lesaunier F, Nguyen T, Heymann S, Truc G, Peiffert D

Cancer Radiother. 2010 Jun;14(3):176-82

[Erectile function after permanent prostate brachytherapy: A long term prospective study about 157 cases]

Marcon N, Cormier L, Peiffert D, Mangin P

Prog Urol. 2010 Apr;20(4):284-91

[Securitization of the bi-site radiotherapy activity as part of the resumption of treatments in the Hospital of Epinal by the team of Alexis Vautrin Nancy Cancer Center]

Marchesi V, Aigle D, Peiffert D, Noel A, Simon JM

Cancer Radiother. 2009 Dec;13(8):740-3

Radiation therapy: the lessons from Epinal and Toulouse accidents

Bourguignon M, Simon JM, Peiffert D, Krembel D

Radioprotection. 2009 Oct-dec;44(4):417-29

[Safety and quality assurance management in radiation oncology "what is the role for qualiticians?": example of the Centre Alexis Vautrin]

Aigle D, Sobczyk C, Androni ML, Peiffert D, Beckendorf V, Marchesi V, Buchheit I, Noel A

Cancer Radiother. 2009 Oct;13(6-7):455-7

[Extracranial stereotactic radiotherapy avancer by robotic radiosurgery: preliminary experience of the center Alexis-Vautrin]

Taste H, Beckendorf V, Bernier V, Graff P, Marchesi V, Noel A, Peiffert D

Bull Cancer. 2009 Sep;96(9):865-74.

[Study on the quality of life of patients suffering from localized prostate cancer treated with HIFU]

Boudrant G, Mangin P, Feuillu B, Peiffert D, Cormier L

Prog Urol. 2009 Sep;19(8):542-52

Keloids treated with postoperative Iridium 192* brachytherapy: a retrospective study.

Arnault JP, Peiffert D, Latarche C, Chassagne JF, Barbaud A, Schmutz JL

J Eur Acad Dermatol Venereol. 2009 Jul;23(7):807-13

[Curative salvage treatment of mediastinal and pleuropulmonar metastatis from anal canal cancer]

Moreau MV, Tournier-Rangeard L, Kaminsky MC, Peiffert D

Cancer Radiother. 2009 Jul;13(4):329-32

[Quality control in pulsed dose rate brachytherapy]

Metayer Y, Meyer P, Brunaud C, Peiffert D

Cancer Radiother. 2009 Jul;13(4):318-22

GEC-ESTRO recommendations for brachytherapy for head and neck squamous cell carcinomas.

Mazeron JJ, Ardiet JM, Haie-Meder C, Kovacs G, Levendag P, Peiffert D, Polo A, Rovirosa A, Strnad V

Radiother Oncol. 2009 May;91(2):150-6

[Radiosurgery of cerebral arteriovenous malformations: a prescription algorithm]

Blanchard N, Bernier V, Anxionnat R, Picard L, Marchal C, Buchheit I, Metayer C, Desandes E, Peiffert D

Cancer Radiother. 2009 Jan;13(1):1-10

Phase I trial of oxaliplatin with fluorouracil, folinic acid and concurrent radiotherapy for oesophageal cancer.

Conroy T, Viret F, Francois E, Seitz JF, Boige V, Ducreux M, Ychou M, Metges JP, Giovannini M, Yataghene Y, Peiffert D

Br J Cancer. 2008 Nov 4;99(9):1395-401

[Brachytherapy for head and neck cancers (nasopharynx excluded)]

Lapeyre M, Belliere A, Hoffstetter S, Peiffert D

Cancer Radiother. 2008 Nov;12(6-7):515-21

[Preliminary results of a French prospective-multicentric study of 3D pulsed dose-rate brachytherapy for cervix carcinoma]

Charra-Brunaud C, Peiffert D

Cancer Radiother. 2008 Nov;12(6-7):527-31

[Optimisation and evaluation of the foetal dose during a radiotherapy of the right parotid]

Marchesi V, Graff P, Noel A, Beckendorf V, Peiffert D

Cancer Radiother. 2008 Sep;12(5):380-4

Radiochemotherapy of locally advanced anal canal carcinoma: prospective assessment of early impact on the quality of life (randomized trial ACCORD 03).

Tournier-Rangeard L, Mercier M, Peiffert D, Gerard JP, Romestaing P, Lemanski C, Mirabel X, Pommier P, Denis B

Radiother Oncol. 2008 Jun;87(3):391-7

[High fetal irradiation: about one pregnant woman receiving infradiaphragmatic radiotherapy for Hodgkin lymphoma]

Moreau MV, Brunaud C, Bologna S, Marchesi V, Hoffstetter S, Peiffert D

Cancer Radiother. 2007 Dec;11(8):495-9

[Brachytherapy for localised prostate cancer]

Peiffert D

Cancer Radiother. 2007 Nov;11(6-7):373-8

[CyberKnife robotic stereotactic radiotherapy: technical aspects and medical indications]

Bondiau PY, Benezery K, Beckendorf V, Peiffert D, Gerard JP, Mirabel X, Noel A, Marchesi V, Lacornerie T, Dubus F, Sarrazin T, Herault J, Marcie S, Angellier G, Lartigau E

Cancer Radiother. 2007 Nov;11(6-7):338-44.

[Epinal radiotherapy accident: passed, present, future]

Peiffert D, Simon JM, Eschwege F

Cancer Radiother. 2007 Nov;11(6-7):309-12

[Clinical and dosimetric analysis of 469 prostate cancer patients treated in France in 2005 by permanent implant brachytherapy using the Iodin 125 seeds IsoSeed Bebig: report to the French Economic committee of health products (CEPS)]

Cosset JM, Gomme S, Peiffert D, Guerif S, Labib A, Hannoun-Levi JM, Martin P, Quetin P, Nguyen TD, Flam T, Thiounn N, Henni M, Rosenwald JC, Housset M, Pontvert D, Asselain B, Chauveinc L

Cancer Radiother. 2007 Jun;11(4):206-13

[Long-term results and prognostic factors of squamous cell carcinoma of the anal canal treated by irradiation]

Tournier-Rangeard L, Peiffert D, Lafond C, Mege A, Metayer Y, Marchesi V, Buchheit I, Uwer L, Conroy T, Kaminsky MC

Cancer Radiother. 2007 Jun;11(4):169-77

[Pulse dose-rate brachytherapy and treatment of uterine cervix cancer: impact of a 3D or a 2D dosimetric support]

Tournat H, Chilles A, Charra-Brunaud C, Peiffert D, Ahmad F, Metayer Y

Cancer Radiother. 2007 Jun;11(4):188-96

[Brachytherapy in France in 2002: results of the ESTRO-PCBE questionnaire]

Peiffert D, Mazeron JJ, Guedea F, Nisin R

Cancer Radiother. 2007 May;11(3):146-9

Impact of intensity-modulated radiotherapy on health-related quality of life for head and neck cancer patients: matched-pair comparison with conventional radiotherapy.

Graff P, Lapeyre M, Desandes E, Ortholan C, Bensadoun RJ, Alfonsi M, Maingon P, Giraud P, Bourhis J, Marchesi V, Mege A, Peiffert D

Int J Radiat Oncol Biol Phys. 2007 Apr 1;67(5):1309-17

Brachytherapy versus prostatectomy in localized prostate cancer: results of a French multicenter prospective medico-economic study.

Buron C, Le Vu B, Cosset JM, Pommier P, Peiffert D, Delannes M, Flam T, Guerif S, Salem N, Chauveinc L, Livartowski A

Int J Radiat Oncol Biol Phys. 2007 Mar 1;67(3):812-22.

[The French preliminary experience of the use of a seed-projector for exclusive iodine 125 prostate brachytherapy: feasibility and acute toxicity]

Pommier P, Delannes M, LeFloch O, Bernier V, Baron MH, Thomas L, Malet C, Bonnet J, Louisot P, Aletti P, Goubard O, Chemin A, Chirat F, Lebivic S, Montbarbon X, Bachaud JM, Votron L, Lasbareilles O, Desmettre O, Bringeon G, Gassa F, Peiffert D

Cancer Radiother. 2006 Dec;10(8):559-64

[Innovation in gynaecological brachytherapy: new technologies, pulse dose-rate brachytherapy, image, definition of new volumes of interest and their impact on dosimetry: application in a clinical research programme "STIC"].

Haie-Meder C, Peiffert D

Cancer Radiother. 2006 Nov;10(6-7):402-9

[What changes were made in the National Thesaurus of Gastrointestinal Cancer in 2005?].

Legoux JL, Bedenne L, Seitz JF, Pezet D, Rougier P, Bouche O, Barbare JC, Andre T, Malka D, Cadiot G, Ruskone-Foumestraux A, Landi B, Peiffert D, Ducreux M, Louvet C, Dorval E

Gastroenterol Clin Biol. 2006 Oct;30(10):1191-5.

Treatment of squamous cell anal canal carcinoma (SCACC) with pulsed dose rate brachytherapy: a retrospective study.

Bruna A, Gastelblum P, Thomas L, Chapet O, Bollet MA, Ardiet JM, Gerard JP, Peiffert D

Radiother Oncol. 2006 Apr;79(1):75-9.

Radiotherapy for solitary extramedullary plasmacytoma in the head-and-neck region: A dose greater than 45 Gy to the target volume improves the local control.

Tournier-Rangeard L, Lapeyre M, Graff-Caillaud P, Mege A, Dolivet G, Toussaint B, Charra-Brunaud C, Hoffstetter S, Marchal C, Peiffert D

Int J Radiat Oncol Biol Phys. 2006 Mar 15;64(4):1013-7

[What is new in brachytherapy?].

Peiffert D

Bull Cancer. 2006 Jan 1;93(1):125-32.

[Insterstitial brachytherapy of localised prostate cancer using iodine 125 permanent implants].

Peiffert D

Cancer Radiother. 2005 Nov;9(6-7):388-93

Anal canal carcinoma: early-stage tumors < or =10 mm (T1 or Tis): therapeutic options and original pattern of local failure after radiotherapy.

Ortholan C, Ramaioli A, Peiffert D, Lusinchi A, Romestaing P, Chauveinc L, Touboul E, Peignaux K, Bruna A, de La Roche G, Lagrange JL, Alzieu C, Gerard JP

Int J Radiat Oncol Biol Phys. 2005 Jun 1;62(2):479-85.